Actively Recruiting
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
Led by University Medical Center Groningen · Updated on 2025-03-30
171
Participants Needed
5
Research Sites
218 weeks
Total Duration
On this page
Sponsors
U
University Medical Center Groningen
Lead Sponsor
U
University of Twente
Collaborating Sponsor
AI-Summary
What this Trial Is About
Stress is a well-established factor in the onset and continuation of burn-out anxiety, mood and psychotic disorders. Furthermore, sleep disturbances predispose and exacerbate mental health symptoms of the condition. In people with mental health problems, higher (social) stress-reactivity and impaired stress-recovery are present which is further aggravated by sleep disturbances and sleep deprivation. Relaxation reduces the stress, which in turn may reduce mental health symptoms, improve daily life functioning and quality of life. The burden of burn-out and psychiatric illness can be decreased by stress-reducing interventions which have been shown to improve quality of life and social and occupational functioning. Although current stress-reducing interventions appear to be efficacious, it must be taken into account that they require mental effort (i.e. attention and concentration of patients) which is often impaired in patients. To bridge this gap, a new e-Health application was developed called VRelax. VRelax is a virtual reality self-management stress-reduction tool (VRelax). This tool requires far less effort than traditional relaxation exercises due to its immersive properties, and has an immediate effect on perceived stress and emotional mental states. In this study, the short-, medium- and long term effect of VRelax + treatment as usual (TAU) compared to TAU and relaxation exercises on symptomatic recovery, level of social functioning, healthcare consumption and societal costs will be investigated.
CONDITIONS
Official Title
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently receiving treatment for burn-out, anxiety disorder, bipolar disorder, post-traumatic stress disorder, depressive disorder and/or psychotic disorder
- Complaints of stress and/or sleep disturbances as reported by patient or therapist
- Age over 18 years
You will not qualify if you...
- Diagnosis of substance use disorder according to DSM-5
- Photosensitive epilepsy with seizures in the past year or organic brain damage
- Insufficient command of Dutch language
- Intellectual disability with estimated IQ below 70
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Mediant
Enschede, Netherlands
Actively Recruiting
2
Forte GGZ
Groningen, Netherlands
Actively Recruiting
3
Lentis
Groningen, Netherlands
Actively Recruiting
4
UMCG
Groningen, Netherlands
Actively Recruiting
5
Argo GGZ
Lochem, Netherlands
Actively Recruiting
Research Team
L
Lisanne Robbemond, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here